BRKR
Bruker Corporation
NASDAQ: BRKR · HEALTHCARE · MEDICAL DEVICES
$44.16
+0.98% today
Updated 2026-05-08
Market cap
$6.44B
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-0.15
Dividend yield
0.53%
52W range
$28 – $56
Volume
2.0M
WallStSmart proprietary scores
42
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+5.3
Quality
C+3.5
Profitability
D5.7
Valuation
C+2/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$46.79
+5.96%
12-Month target
—
—
Intrinsic (DCF)
$58.89
Margin of safety
+27.95%
2 Strong Buy7 Buy4 Hold1 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $47.00M — positive
+ 27.95% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at -0.25%
- Revenue declining -0.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.96B | $3.37B | $3.44B | $3.44B |
| Net income | $296.60M | $427.20M | $113.10M | $-8.60M | $14.40M |
| EPS | — | — | — | — | $-0.15 |
| Free cash flow | $143.00M | $243.20M | $136.00M | $43.30M | $47.00M |
| Profit margin | 11.72% | 14.41% | 3.36% | -0.25% | -0.25% |
Peer comparison
Smart narrative
Bruker Corporation trades at $44.16. Our Smart Value Score of 42/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. TTM revenue stands at $3.44B. with profit margins at -0.25%. Our DCF model estimates intrinsic value at $58.89.
Frequently asked questions
What is Bruker Corporation's stock price?
Bruker Corporation (BRKR) trades at $44.16.
Is Bruker Corporation overvalued?
Smart Value Score 42/100 (Grade D, Sell). DCF value $58.89.
What is the price target of Bruker Corporation (BRKR)?
The analyst target price is $46.79, representing +6.0% upside from the current price of $44.16.
What is the intrinsic value of Bruker Corporation (BRKR)?
Based on our DCF model, intrinsic value is $58.89, a +27.9% margin of safety versus $44.16.
What is Bruker Corporation's revenue?
TTM revenue is $3.44B.
Piotroski F-Score?
2/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.87x
ROE-0.38%
Beta1.12
50D MA$37.11
200D MA$39.51
Shares out0.15B
Float0.10B
Short ratio—
Avg volume2.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—